Table 2.
Univariable |
Multivariable |
|||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age (≥73) | 1.63 | 1.17–2.29 | 0.0038 | 1.39 | 0.88–2.22 | 0.1574 |
initial PSA (≥450) | 0.98 | 0.70–1.36 | 0.8942 | |||
GS ≥ 9 | 1.69 | 1.15–2.55 | 0.0068 | 1.62 | 0.98–2.75 | 0.0587 |
T stage (≥T3b) | 1.68 | 1.11–2.62 | 0.0121 | 0.99 | 0.58–1.79 | 0.9800 |
N stage (positive) | 2.07 | 1.42–3.09 | 0.0001 | 1.61 | 0.97–2.76 | 0.0643 |
Hb (<13) | 1.60 | 1.14–2.25 | 0.0062 | 1.14 | 0.71–1.85 | 0.5915 |
LDH (≥ 208) | 2.43 | 1.72–3.47 | < 0.0001 | 2.54 | 1.61–4.11 | < 0.0001 |
ALP (≥408) | 1.76 | 1.25–2.49 | 0.0011 | 1.46 | 0.91–2.36 | 0.1145 |
NLR (≥2.6) | 0.85 | 0.60–1.20 | 0.3521 | |||
CRP (≥0.2) | 1.88 | 1.24–2.91 | 0.0030 | 1.41 | 0.87–2.32 | 0.1659 |
ALP, alkaline phosphatase; CI, confidence interval; CRP, C-reactive protein; GS, Gleason score sum; Hb, haemoglobin; HR, hazard ratio; LDH, lactate dehydrogenase; NLR, neutrophil-lymphocyte ratio; PSA, prostate-specific antigen.